|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2004
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis
1 Respiratory Diseases Division, and 2 Anaesthesiology and Intensive Care Unit, Istituto di Ricovero e Cura a Carattere Scientifico, Policlinico S. Matteo, University of Pavia, Pavia, Italy
CORRESPONDENCE: I. Cerveri, Division of Respiratory Diseases, IRCCS Policlinico S. Matteo, via Taramelli 5, 27100, Pavia, Italy. Fax: 39 0382423150. E-mail: i.cerveri@libero.it
Keywords: Bronchoalveolar lavage, follow-up studies, pulmonary alveolar proteinosis, respiratory function tests
Received: September 11, 2003
Accepted November 24, 2003
Whole lung lavage (WLL) is still the gold-standard therapy for pulmonary alveolar proteinosis (PAP). The few studies on the duration of the effect of WLL, belonging to a rather remote period, show significant but transient benefits.
In 21 patients with idiopathic PAP, the duration of any benefit and, in 16 of them, the time course of lung function improvement (at baseline, 1 week, 6 months, 1 yr and then every 2 yrs after WLL) were evaluated. The present WLL technique takes longer, is invasively monitored and partially modified with respect to past techniques.
More than 70% of patients remained free from recurrent PAP at 7 yrs. The bulk of the improvement in spirometric results was almost completely gained in the immediate post-WLL period due to the efficient clearance of the alveoli. At a median of 5 yrs, recovery of diffusing capacity of the lung for carbon monoxide was incomplete (75±19% of the predicted value) and there were residual gas exchange abnormalities (alveolar to arterial oxygen tension difference 3.6±1.5 kPa (27±11 mmHg)) and exercise limitation, probably explained by engorgement of lymphatic vessels.
In conclusion, whole lung lavage for idiopathic pulmonary alveolar proteinosis is currently a safe procedure in an experienced setting, and provides long-lasting benefits in the majority of patients.
This article has been cited by other articles:
|
|
 |
|
  G. Michaud, C. Reddy, and A. Ernst Whole-Lung Lavage for Pulmonary Alveolar Proteinosis Chest, December 1, 2009; 136(6): 1678 - 1681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Luisetti, G. Rodi, C. Perotti, I. Campo, F. Mariani, E. Pozzi, and B. C. Trapnell Plasmapheresis for treatment of pulmonary alveolar proteinosis Eur. Respir. J., May 1, 2009; 33(5): 1220 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Dexter, G. P. Cosgrove, and I. S. Douglas Managing a Rare Condition Presenting With Intractable Hypoxemic Respiratory Failure Chest, January 1, 2007; 131(1): 320 - 327. [Full Text] [PDF]
|
|
|
|
 |
|
 O C Ioachimescu and M S Kavuru Pulmonary alveolar proteinosis Chronic Respiratory Disease, July 1, 2006; 3(3): 149 - 159. [Abstract] [PDF]
|
|
|
|
|
|
M. E. Wylam, R. Ten, U. B. S. Prakash, H. F. Nadrous, M. L. Clawson, and P. M. Anderson Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis. Eur. Respir. J., March 1, 2006; 27(3): 585 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Spock Long-term survival of paediatric patients with pulmonary alveolar proteinosis treated with lung lavage Eur. Respir. J., June 1, 2005; 25(6): 1127 - 1127. [Full Text] [PDF]
|
|
|
|
|
|
C. Morgan The benefits of whole lung lavage in pulmonary alveolar proteinosis Eur. Respir. J., April 1, 2004; 23(4): 503 - 505. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |